Novartis cancer division races to catch up with rivals
Reuters: Health News
ZURICH (Reuters) - Novartis is making progress in its bid to catch rivals developing drugs that harness the immune system to fight cancer, one of its top research scientists and latest recruit from Harvard University told Reuters in an interview.
No comments:
Post a Comment